However, due to its incretin function, GLP-1 is also known to normalize plasma glucose, especially in patients suffering from obesity and diabetes which might act as a counter mechanism for the increased hyperglycemia-induced impaired gastric motility observed after PD [36,37]. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.